Cargando…
Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection
Treatment response is heterogeneous. However, the classical methods treat the treatment response as homogeneous and estimate the average treatment effects. The traditional methods are difficult to apply to precision oncology. Artificial intelligence (AI) is a powerful tool for precision oncology. It...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759680/ https://www.ncbi.nlm.nih.gov/pubmed/33362849 http://dx.doi.org/10.3389/fgene.2020.585804 |
_version_ | 1783627158053191680 |
---|---|
author | Ge, Qiyang Huang, Xuelin Fang, Shenying Guo, Shicheng Liu, Yuanyuan Lin, Wei Xiong, Momiao |
author_facet | Ge, Qiyang Huang, Xuelin Fang, Shenying Guo, Shicheng Liu, Yuanyuan Lin, Wei Xiong, Momiao |
author_sort | Ge, Qiyang |
collection | PubMed |
description | Treatment response is heterogeneous. However, the classical methods treat the treatment response as homogeneous and estimate the average treatment effects. The traditional methods are difficult to apply to precision oncology. Artificial intelligence (AI) is a powerful tool for precision oncology. It can accurately estimate the individualized treatment effects and learn optimal treatment choices. Therefore, the AI approach can substantially improve progress and treatment outcomes of patients. One AI approach, conditional generative adversarial nets for inference of individualized treatment effects (GANITE) has been developed. However, GANITE can only deal with binary treatment and does not provide a tool for optimal treatment selection. To overcome these limitations, we modify conditional generative adversarial networks (MCGANs) to allow estimation of individualized effects of any types of treatments including binary, categorical and continuous treatments. We propose to use sparse techniques for selection of biomarkers that predict the best treatment for each patient. Simulations show that MCGANs outperform seven other state-of-the-art methods: linear regression (LR), Bayesian linear ridge regression (BLR), k-Nearest Neighbor (KNN), random forest classification [RF (C)], random forest regression [RF (R)], logistic regression (LogR), and support vector machine (SVM). To illustrate their applications, the proposed MCGANs were applied to 256 patients with newly diagnosed acute myeloid leukemia (AML) who were treated with high dose ara-C (HDAC), Idarubicin (IDA) and both of these two treatments (HDAC+IDA) at M. D. Anderson Cancer Center. Our results showed that MCGAN can more accurately and robustly estimate the individualized treatment effects than other state-of-the art methods. Several biomarkers such as GSK3, BILIRUBIN, SMAC are identified and a total of 30 biomarkers can explain 36.8% of treatment effect variation. |
format | Online Article Text |
id | pubmed-7759680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77596802020-12-26 Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection Ge, Qiyang Huang, Xuelin Fang, Shenying Guo, Shicheng Liu, Yuanyuan Lin, Wei Xiong, Momiao Front Genet Genetics Treatment response is heterogeneous. However, the classical methods treat the treatment response as homogeneous and estimate the average treatment effects. The traditional methods are difficult to apply to precision oncology. Artificial intelligence (AI) is a powerful tool for precision oncology. It can accurately estimate the individualized treatment effects and learn optimal treatment choices. Therefore, the AI approach can substantially improve progress and treatment outcomes of patients. One AI approach, conditional generative adversarial nets for inference of individualized treatment effects (GANITE) has been developed. However, GANITE can only deal with binary treatment and does not provide a tool for optimal treatment selection. To overcome these limitations, we modify conditional generative adversarial networks (MCGANs) to allow estimation of individualized effects of any types of treatments including binary, categorical and continuous treatments. We propose to use sparse techniques for selection of biomarkers that predict the best treatment for each patient. Simulations show that MCGANs outperform seven other state-of-the-art methods: linear regression (LR), Bayesian linear ridge regression (BLR), k-Nearest Neighbor (KNN), random forest classification [RF (C)], random forest regression [RF (R)], logistic regression (LogR), and support vector machine (SVM). To illustrate their applications, the proposed MCGANs were applied to 256 patients with newly diagnosed acute myeloid leukemia (AML) who were treated with high dose ara-C (HDAC), Idarubicin (IDA) and both of these two treatments (HDAC+IDA) at M. D. Anderson Cancer Center. Our results showed that MCGAN can more accurately and robustly estimate the individualized treatment effects than other state-of-the art methods. Several biomarkers such as GSK3, BILIRUBIN, SMAC are identified and a total of 30 biomarkers can explain 36.8% of treatment effect variation. Frontiers Media S.A. 2020-12-11 /pmc/articles/PMC7759680/ /pubmed/33362849 http://dx.doi.org/10.3389/fgene.2020.585804 Text en Copyright © 2020 Ge, Huang, Fang, Guo, Liu, Lin and Xiong. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Ge, Qiyang Huang, Xuelin Fang, Shenying Guo, Shicheng Liu, Yuanyuan Lin, Wei Xiong, Momiao Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection |
title | Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection |
title_full | Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection |
title_fullStr | Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection |
title_full_unstemmed | Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection |
title_short | Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection |
title_sort | conditional generative adversarial networks for individualized treatment effect estimation and treatment selection |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759680/ https://www.ncbi.nlm.nih.gov/pubmed/33362849 http://dx.doi.org/10.3389/fgene.2020.585804 |
work_keys_str_mv | AT geqiyang conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection AT huangxuelin conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection AT fangshenying conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection AT guoshicheng conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection AT liuyuanyuan conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection AT linwei conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection AT xiongmomiao conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection |